The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation-Reference-Cited by-同舟云学术

The comparison of non-vitamin K antagonist oral anticoagulants versus well-managed warfarin with a lower INR target of 1.5 to 2.5 in Asians patients with non-valvular atrial fibrillation

Published:2019-03-18 Issue:3 Volume:14 Page:e0213517
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chan Yi-Hsin,Lee Kuang-Tso,Kao Yi-Wei,Huang Chien-Ying,Chen Yung-Lung,Hang Samuel Chi-Ling,Chu Pao-Hsien^ORCID

Funder

Chang Gung Memorial Hospital, Linkou

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;RG Hart;Ann Intern Med,2007

2. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS;P Kirchhof;Eur Heart J,2016

3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society;CT January;J Am Coll Cardiol,2014

4. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation;AY Shen;J Am Coll Cardiol,2007

5. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis;CJ van Asch;Lancet Neurol,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia;Thrombosis and Haemostasis;2023-09-30

2. Bidirectional effects of oral anticoagulants on gut microbiota in patients with atrial fibrillation;Frontiers in Cellular and Infection Microbiology;2023-03-24

3. Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study;Journal of Clinical Medicine;2021-08-30

4. Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants;Cardiovascular Diabetology;2020-05-13

5. New perspective on the risk markers for left atrial thrombosis in patients with atrial fibrillation;European Journal of Preventive Cardiology;2020-03-19